# ResMed acquires Ectosense, maker of NightOwl home sleep test

ResMed completed the acquisition of Ectosense, maker of the NightOwl cloud-connected home sleep test device. The deal expands ResMed's diagnostic portfolio for sleep apnea.

- Type: Acquisition
- Announced: 2021-10-01
- Where: United States
- Status: completed
- Products: home sleep test device, NightOwl
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [ResMed](https://endata.com/companies/35402.md) (acquirer)
- [Ectosense](https://endata.com/companies/58121.md) (target)

## Sources

- [sleepreviewmag.com](https://sleepreviewmag.com/sleep-diagnostics/home-testing/home-apnea-testing/resmed-acquires-ectosense/), 2021-10-01: "We believe Ectosense's digital and easy-to-use solutions in the hands of both sleep lab technicians and consumers worldwide can help significantly increase diagnoses, as well as general awareness of this highly prevalent, 100% treatable disease."
- [sleepworldmagazine.com](https://sleepworldmagazine.com/2021/10/04/resmed-acquires-hsat-maker-ectosense/), 2021-10-04: "We believe Ectosense’s digital and easy-to-use solutions in the hands of both sleep lab technicians and consumers worldwide can help significantly increase diagnoses."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.